Latest Expert Exchange Queries
sitemapHome | Registration | Job Portal for CA's | Expert Exchange | Currency Converter | Post Matrimonial Ads | Post Property Ads
News shortcuts: From the Courts | News Headlines | VAT (Value Added Tax) | Service Tax | Sales Tax | Placements & Empanelment | Various Acts & Rules | Latest Circulars | New Forms | Forex | Auditing | Direct Tax | Customs and Excise | ICAI | Corporate Law | Markets | Students | General | Indirect Tax | Mergers and Acquisitions | Continuing Prof. Edu. | Budget Extravaganza | Transfer Pricing
Popular Search: form 3cd :: ACCOUNTING STANDARDS :: articles on VAT and GST in India :: Central Excise rule to resale the machines to a new company :: TAX RATES - GOODS TAXABLE @ 4% :: TDS :: ICAI offer Get Windows 7,Office 2010 in Rs.799 Taxes :: cpt :: empanelment :: ARTICLES ON INPUT TAX CREDIT IN VAT :: list of goods taxed at 4% :: VAT Audit :: due date for vat payment :: ACCOUNTING STANDARD :: VAT RATES
« Budget Extravaganza »
 Budget advancement helps Centre, states start spending early
 Five things that you can expect from the Mumbai civic budget today
 GST all set for July 1 rollout but casts shadow on state budgets
 Income-Tax collection revised in Rajasthan budget
 No new taxes likely in Maharashtra Budget
 H.P. budget devoid of any financial prudence
 GST, demonetisation todecide budget priorities
 Railways to come up with mini-budget tomorrow
 Budget today, but GST kills the tax suspense
 Budget 2017 does little to expand taxpayer base, salaried still bear brunt of taxes
 Six things Finance Minister did not tell you in Budget 2017

Budget boosters that the pharma industry
February, 17th 2010

The countdown to this years Budget has begun, and the pharmaceutical industry once again waits to get the desired attention from the Finance Ministry, says Hitesh Gajaria, Executive Director, KPMG.

While the wish list of the industry remains similar to that of last year, what is to be seen is whether the Government will fulfil the key demands of the sector, he wryly adds, during a recent pre-Budget email interaction with Business Line.

As the Indian Government makes a transition from economic stimulus to combat slowdown to gradual withdrawal of stimulus to nurture growth, the pharma industry expects the Government to play a role which will truly partner the industry so that Healthcare for all becomes a reality, wishes Gajaria.

Excerpts from the interview

On the growth trajectory

The domestic pharmaceutical industry, which had demonstrated its resilience in combating the economic slowdown in 2008 vis--vis other sectors, has once again exhibited its strength and has bounced back with full swing, witnessing close to 17 per cent growth in 2009 the highest in two years after 2006. The exports segment is also gradually reverting to its high-growth trajectory backed by the recovering global economy.

While the industry seems to be well-positioned to tap the opportunities that lie in store, it has expressed a strong desire for further Government support in the form of incentives and tax sops in order to leverage its true potential as a globally important pillar of the pharmaceuticals value chain.

Although the Government is increasingly focusing on providing affordable healthcare to all, the steps taken till now have fallen short of the industry expectations. The last couple of Budgets have not been very encouraging as some of the industrys long-standing demands have remained unmet.

On R&D

The most important issue is the need to further incentivise research and development (R&D) efforts. This highly capital-intensive area with a long gestation period for payback is fraught with the challenge of limited funding capacity of domestic players.

Indian pharma companies have largely relied on internally-generated revenues (primarily from their generics business) to fund their R&D programmes, due to the relatively low risk appetite of capital markets and the lack of experienced PE (private equity) players to invest in this business.

An increase in the deduction on R&D from 150 per cent to 200 per cent will likely ease this pressure by allowing for increase in allocation to this segment. The industry also calls for expanding the scope of R&D expenditure that is presently allowed for the said weighted deduction; for instance, it should be extended to include expenditure incurred on filing applications to register products for sale outside India with any regulatory authority outside India.

On indirect taxes

While the reduction of customs duty on around 10 life-saving drugs from 10 per cent to 5 per cent was a welcome move, the industry expects the Government to bring more such drugs under its ambit, thereby making these drugs affordable.

The Government is working towards the implementation of Goods and Services Tax (GST) in the country shortly. The pharma industry expects the Government to ensure a smooth transition from the existing indirect taxes regime to GST, which is expected to eliminate cascading in taxes while reducing transaction costs thus having a positive impact on the pharma industry supply chains.

On MAT hopes

The hike in Minimum Alternate Tax (MAT) from 10 per cent to 15 per cent was a dampener for the industry in the last Budget. The pharma industry hopes for the restoration of MAT rate back to 10 per cent.

On tax holiday

A further extension of the sunset clause benefits to export-oriented units under Section 10B beyond FY11 will help in supporting the expansion of the export segment.

The denial of the benefit of the tax holiday to units in the special economic zones (SEZs), proposed in the Direct Taxes Code Bill should never be enacted as such a move will kill the fledgling efforts of export-oriented pharma companies that have made a strategic decision to put in long-term capital commitment in manufacturing units in SEZs.

Home | About Us | Terms and Conditions | Contact Us
Copyright 2017 CAinINDIA All Right Reserved.
Designed and Developed by Binarysoft Technologies Pvt. Ltd.
Software Outsourcing Company Offshore Software Outsourcing Software Outsourcing Company India Offshore Outsourcing Company India Software BPO Software Business Process Outsourcing Software Outsourcing India Offsho

Transfer Pricing | International Taxation | Business Consulting | Corporate Compliance and Consulting | Assurance and Risk Advisory | Indirect Taxes | Direct Taxes | Transaction Advisory | Regular Compliance and Reporting | Tax Assessments | International Taxation Advisory | Capital Structuring | Withholding tax advisory | Expatriate Tax Reporting | Litigation | Badges | Club Badges | Seals | Military Insignias | Emblems | Family Crest | Software Development India | Software Development Company | SEO Company | Web Application Development | MLM Software | MLM Solutions